Esperion Therapeutics Inc... (ESPR)
1.50
-0.11 (-6.83%)
At close: Mar 28, 2025, 3:58 PM
1.50
-0.29%
After-hours: Mar 28, 2025, 07:59 PM EDT
Esperion Therapeutics Balance Sheet Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY02 | FY01 | FY00 | FY99 |
Cash & Equivalents | 144.76M | 82.25M | 124.78M | 208.89M | 304.96M | 166.13M | 36.97M | 34.47M | 38.16M | 77.34M | 85.04M | 56.54M | 6.51M | 1.57M | 40.5M | 70.29M | 70.23M | 5.9M |
Short-Term Investments | n/a | n/a | 42.09M | 50.44M | n/a | 34.65M | 99.05M | 165.73M | 173.42M | 134.93M | 20.8M | 3.53M | n/a | n/a | 4.35M | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | 42.09M | 50.44M | n/a | 34.65M | 99.29M | 239.15M | 204.32M | 215.24M | 56.54M | 17.54M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | -42.09M | 50M | -7.36M | -34.65M | -99.05M | -165.73M | -173.42M | -134.93M | -20.8M | n/a | -174.03K | 10.35K | 35K | 633K | 534K | n/a |
Receivables | 80.14M | 48.49M | 33.73M | 22.93M | 12.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | 94.49M | 65.62M | 35.2M | 34.39M | 16.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 18.6M | 4.7M | 10.89M | 12.31M | 12.41M | 10.93M | 6.61M | 3.73M | 1.99M | 2.13M | 858K | 919.51K | 367.22K | 292.96K | 410K | 1M | 1.11M | 139K |
Total Current Assets | 338M | 201.06M | 246.68M | 328.97M | 345.9M | 211.71M | 142.63M | 203.92M | 213.58M | 214.39M | 106.77M | 60.62M | 7.14M | 1.86M | 45.26M | 71.29M | 71.34M | 6.04M |
Property-Plant & Equipment | 5.77M | 4.67M | 1.2M | 2.56M | 7.31M | 2.68M | 520K | 435K | 674K | 807K | 780K | 80.81K | 120.21K | 251.53K | 3M | 3.31M | 2.5M | 1.96M |
Goodwill & Intangibles | 56K | 56K | 56K | 56K | 56K | 56K | 56K | 56K | 56K | 56K | 56K | 55.74K | 53.83K | 53.83K | 3.11M | 3.11M | 3.5M | n/a |
Total Long-Term Assets | 5.82M | 4.73M | 1.26M | 52.62M | 7.36M | 2.73M | 819K | 73.91M | 31.64M | 81.18M | 36.58M | 17.67M | 174.03K | 315.7K | 6.14M | 7.05M | 6.54M | 1.96M |
Total Assets | 343.82M | 205.8M | 247.94M | 381.59M | 353.26M | 214.45M | 143.45M | 277.83M | 245.21M | 295.57M | 143.34M | 78.29M | 7.31M | 2.18M | 51.41M | 78.34M | 77.88M | 8M |
Account Payables | 51.65M | 31.72M | 23.04M | 17.56M | 51.98M | 28.86M | 44.89M | 20.38M | 4.59M | 707K | 2.04M | 2.23M | 476.28K | 691.18K | 1.69M | 2.92M | 3.94M | 1.43M |
Deferred Revenue | 8.52M | 25.4M | 3.51M | 5.68M | 1.66M | 2.15M | n/a | 38K | 40K | 37K | 107K | n/a | 1.19M | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 57.32M | 36.38M | 25.14M | 12.69M | 7.98M | 5.69M | n/a | 1.04M | 1.71M | 1.6M | 638K | n/a | 15.24M | n/a | 1.06M | 863K | 697K | 495K |
Other Current Liabilities | 128.75M | 62.72M | 40.62M | 37.42M | 37.84M | 34.58M | 19.4M | 11.69M | 9.24M | 3.28M | 2.71M | 1.88M | 1.44M | 644.83K | 2.19M | 2.57M | 2.53M | 980.38K |
Total Current Liabilities | 246.23M | 156.22M | 92.31M | 73.35M | 94.07M | 66.08M | 64.33M | 33.14M | 15.59M | 5.63M | 5.49M | 4.2M | 17.17M | 1.34M | 4.93M | 6.36M | 7.16M | 2.9M |
Long-Term Debt | 240.29M | 504.57M | 260.56M | 258.8M | 182.82M | 1.11M | n/a | n/a | 1.02M | 2.69M | 4.3M | n/a | 7.53M | 6.9M | 7.73M | 5.48M | 3.03M | 2.28M |
Other Long-Term Liabilities | 246.02M | n/a | 218.84M | 245.74M | 172.5M | 127.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.73M | -5.48M | -3.03M | -219 |
Total Long-Term Liabilities | 486.31M | 504.57M | 479.41M | 505.18M | 355.32M | 128.42M | n/a | n/a | 1.02M | 2.69M | 4.3M | n/a | 7.53M | 6.9M | 7.73M | 5.48M | 3.03M | 2.28M |
Total Liabilities | 732.54M | 660.79M | 571.72M | 578.53M | 449.39M | 194.5M | 64.33M | 33.14M | 16.61M | 8.31M | 9.79M | 4.2M | 24.7M | 8.24M | 12.66M | 11.84M | 10.19M | 5.18M |
Total Debt | 297.6M | 540.95M | 260.95M | 260.2M | 185.41M | 1.56M | n/a | 1.04M | 2.73M | 4.29M | 4.94M | n/a | 22.77M | 6.9M | 8.79M | 6.34M | 3.72M | 2.78M |
Common Stock | 196K | 118K | 75K | 61K | 26K | 27K | 27K | 26K | 23K | 23K | 20K | 15.36K | 346.00 | 308.00 | 29K | 29K | 26K | 1.94K |
Retained Earnings | -1.6B | -1.55B | -1.34B | -1.11B | -838.82M | -695.27M | -598.1M | -396.29M | -229.2M | -154.22M | -104.44M | -68.06M | -41.98M | -30.23M | -94.05M | -65.32M | -40.39M | -12.81M |
Comprehensive Income | n/a | n/a | -2K | -31K | 0.00 | 23K | -319K | -845K | -172K | -482K | -59K | -3.03K | -1.17M | -1.04M | -3.69M | -2.42M | -1.26M | -471.62K |
Shareholders Equity | -388.72M | -454.99M | -1.34B | -1.11B | -838.82M | -695.27M | -598.1M | 244.69M | 228.6M | 287.26M | 133.55M | 74.09M | -17.39M | -6.06M | 38.74M | 66.5M | 67.69M | 2.81M |
Total Investments | n/a | n/a | 84.17M | 100.88M | n/a | 69.3M | 99.29M | 239.15M | 204.32M | 215.24M | 56.54M | 21.06M | n/a | n/a | 4.35M | n/a | n/a | n/a |